• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过血凝抑制试验(HI)、酶联免疫吸附测定(ELISA)和中和试验测定,健康老年人对甲型H1N1流感疫苗的抗体反应发生改变。

Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay.

作者信息

Remarque E J, de Bruijn I A, Boersma W J, Masurel N, Ligthart G J

机构信息

Department of Internal Medicine, Leiden University Medical Centre, The Netherlands.

出版信息

J Med Virol. 1998 May;55(1):82-7. doi: 10.1002/(sici)1096-9071(199805)55:1<82::aid-jmv13>3.0.co;2-1.

DOI:10.1002/(sici)1096-9071(199805)55:1<82::aid-jmv13>3.0.co;2-1
PMID:9580890
Abstract

To determine the influence of ageing per se as well as of priming histories on the antibody response to influenza vaccination, haemagglutination inhibition (HI), ELISA IgG, IgA, IgM and neutralizing antibody titres were studied in 43 healthy young subjects (mean age 23 years) and 55 healthy elderly people (mean age 79 years). The HI and ELISA lgG responses to the A/Guizhou/54/89 strain (H3N2) for which both the young and the elderly had similar priming histories were equal. By contrast, the HI and IgG responses to A/Taiwan/1/86 (H1N1), where the priming histories were different, were lower in the elderly (P < 0.05). Influenza-specific IgA responses in the elderly tended to be higher for all vaccine strains. Influenza-specific postvaccination IgM titres were similar or tended to be higher in the elderly. A subgroup of elderly subjects (18%) who did not express HI activity to the A/Taiwan/1/86 (H1N1) vaccine strain, reacted in the HI assay with the closely related A/Singapore/6/86 (H1N1) strain. These elderly people, however, produced lgG antibodies which neutralized A/Taiwan/1/86 virus in vitro. It is concluded that the elderly are capable of mounting antibody responses similar to those observed in the young. Moreover, the observed age-related differences in antibody responses to H1N1 strains are probably not due to ageing of the immune system itself, but are determined by differences in priming histories.

摘要

为了确定衰老本身以及免疫初免史对流感疫苗抗体反应的影响,我们对43名健康年轻受试者(平均年龄23岁)和55名健康老年人(平均年龄79岁)的血凝抑制(HI)、ELISA IgG、IgA、IgM和中和抗体滴度进行了研究。年轻和老年受试者对A/贵州/54/89株(H3N2)的HI和ELISA IgG反应相同,因为他们的免疫初免史相似。相比之下,对A/台湾/1/86(H1N1)株的HI和IgG反应,由于免疫初免史不同,老年人的反应较低(P<0.05)。老年人对所有疫苗株的流感特异性IgA反应往往更高。接种疫苗后,老年人的流感特异性IgM滴度相似或往往更高。一组对A/台湾/1/86(H1N1)疫苗株无HI活性的老年受试者(18%),在HI试验中对密切相关的A/新加坡/6/86(H1N1)株有反应。然而,这些老年人产生的IgG抗体在体外可中和A/台湾/1/86病毒。结论是,老年人能够产生与年轻人相似的抗体反应。此外,观察到的老年人对H1N1株抗体反应的年龄差异可能不是由于免疫系统本身的衰老,而是由免疫初免史的差异决定的。

相似文献

1
Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay.通过血凝抑制试验(HI)、酶联免疫吸附测定(ELISA)和中和试验测定,健康老年人对甲型H1N1流感疫苗的抗体反应发生改变。
J Med Virol. 1998 May;55(1):82-7. doi: 10.1002/(sici)1096-9071(199805)55:1<82::aid-jmv13>3.0.co;2-1.
2
Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.流感疫苗接种后血清抗体反应出现交叉反应但亲和力无变化。
Vaccine. 1995 Nov;13(16):1522-8. doi: 10.1016/0264-410x(95)00095-i.
3
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.接种疫苗前的免疫力和对细胞培养衍生的全病毒 H1N1 疫苗的免疫反应与季节性流感疫苗相似。
Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.
4
Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.MF59佐剂A/H1N1大流行性流感疫苗在3至17岁儿童中的安全性和免疫原性。
Vaccine. 2015 Jan 1;33(1):174-81. doi: 10.1016/j.vaccine.2014.10.085. Epub 2014 Nov 11.
5
Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.在成年和老年血液透析患者中,对标准单剂量无佐剂的 2009 年大流行性 H1N1 流感病毒 A 疫苗的免疫反应不佳。
Vaccine. 2012 Jul 13;30(33):5009-18. doi: 10.1016/j.vaccine.2012.05.016. Epub 2012 May 30.
6
Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift.在抗原性低漂移情况下,初始免疫不佳的成年人接种疫苗后诱导产生的甲型H1N1流感病毒血凝抑制抗体
Vaccine. 1993;11(10):1013-7. doi: 10.1016/0264-410x(93)90126-i.
7
Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients.
Exp Gerontol. 1999 Jan;34(1):109-15. doi: 10.1016/s0531-5565(98)00060-6.
8
Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.减毒甲型H1N1流感病毒在老年人中的感染力降低:与血清及局部抗体的相关性
J Am Geriatr Soc. 1992 Feb;40(2):163-7. doi: 10.1111/j.1532-5415.1992.tb01938.x.
9
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.一项旨在确定单价 A/H1N1 流感大流行疫苗在健康成年和老年受试者中最佳抗原和 MF59(®)佐剂剂量的随机临床试验。
Vaccine. 2012 May 14;30(23):3470-7. doi: 10.1016/j.vaccine.2012.03.017. Epub 2012 Mar 22.
10
The relationship between influenza vaccine-induced specific antibody responses and vaccine-induced nonspecific autoantibody responses in healthy older women.
J Gerontol. 1992 Mar;47(2):M50-5. doi: 10.1093/geronj/47.2.m50.

引用本文的文献

1
A platform for the rapid screening of equine immunoglobins F (ab)2 derived from single equine memory B cells able to cross-neutralize to influenza virus.用于从单个马记忆 B 细胞中快速筛选能够中和流感病毒的马免疫球蛋白 F(ab')2 的平台。
Emerg Microbes Infect. 2024 Dec;13(1):2396864. doi: 10.1080/22221751.2024.2396864. Epub 2024 Sep 27.
2
Advances in Detection Techniques for the H5N1 Avian Influenza Virus.H5N1 禽流感病毒检测技术的进展。
Int J Mol Sci. 2023 Dec 5;24(24):17157. doi: 10.3390/ijms242417157.
3
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
在 COVID-19 疫苗接种运动初期,比利时养老院居民和工作人员中 SARS-CoV-2 抗体的流行情况。
Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28.
4
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.比利时首次 BNT162b2 疫苗接种活动 6 个月后,接种疫苗的养老院居民和工作人员中 SARS-CoV-2 抗体流行率下降:一项前瞻性队列研究。
Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361.
5
A Complex Dance: Measuring the Multidimensional Worlds of Influenza Virus Evolution and Anti-Influenza Immune Responses.一场复杂的舞蹈:测量流感病毒进化与抗流感免疫反应的多维世界
Pathogens. 2019 Nov 15;8(4):238. doi: 10.3390/pathogens8040238.
6
Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates.连续读取与基于滴度的流感疫苗试验检测方法比较:敏感性、特异性和假阳性率。
Comput Math Methods Med. 2019 May 8;2019:9287120. doi: 10.1155/2019/9287120. eCollection 2019.
7
Improved Specificity and False Discovery Rates for Multiplex Analysis of Changes in Strain-Specific Anti-Influenza IgG.提高多重分析流感特异性 IgG 变化的特异性和假发现率。
Comput Math Methods Med. 2019 Apr 15;2019:3053869. doi: 10.1155/2019/3053869. eCollection 2019.
8
A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.一种基于神经氨酸酶活性的微量中和测定法,用于评估针对流感 H5 和 H7 疫苗的抗体反应。
PLoS One. 2018 Nov 15;13(11):e0207431. doi: 10.1371/journal.pone.0207431. eCollection 2018.
9
Immunosenescence in neurocritical care.神经重症监护中的免疫衰老
J Intensive Care. 2018 Oct 12;6:65. doi: 10.1186/s40560-018-0333-5. eCollection 2018.
10
Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza.抗体介导的流感病毒异亚型免疫的多维测量
PLoS One. 2015 Jun 23;10(6):e0129858. doi: 10.1371/journal.pone.0129858. eCollection 2015.